Sotera Health CompanySHCNASDAQ
Loading
EV/EBITDA Over TimeExpanding
Percentile Rank57
5Y CAGR-5.2%
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

5Y CAGR
-5.2%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
202522.87+70.2%
202413.44-19.2%
202316.63+107.3%
2022-227.99-1201.4%
202120.70-30.9%
202029.94-8.4%
201932.70+23.5%
201826.47-